Companies: 10,795·Total market cap: $144.5T
Edgewell Personal Care Company

Edgewell Personal Care Company

EPCNYSEConsumer Defensive● Active
$20.76
+$0.89(+4.45%)
Market Cap$956417921
P/E Ratio
52W High$27.47
52W Low$15.73
Overview

Edgewell Personal Care Company (EPC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

epc · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 17 Wall Street analysts in the past 3 months

SellBuy

Hold

17 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
11
Sell
0
Strong Sell
0
Total: 17 · Buy rate: 35.3%

12-Month Price Target

High

$26.00

Consensus

$23.50

+18.3% upside

Low

$21.00

Median: $23.5 · Last Close: $19.87

The Edgewell Personal Care Company (EPC) analyst consensus is Hold, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month EPC price target is $23.50, representing +18.3% upside from the current price of $19.87.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $24 (18.3%)

Consensus Target

$23.50

18.3% upside

High Target

$26

30.9%

Low Target

$21

5.7%

Current Price

$19.87

as of today

Based on analyst price targets, the EPC stock price prediction for the next 12 months ranges from $21 to $26. The consensus EPC price forecast of $23.50 implies 18.3% upside from the current price of $19.87.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$20.503.16%

1-day model range: $20.36–$20.64. Peak: $20.64 (+3.16%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$17-13.4%
2028$16-19.8%
2029$15-23.0%
2030$15-24.7%
2031-25.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%0%50%
7Buy
0Neutral
7Sell
RSI (14)86.1Overbought
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · EPC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$18.93BUY
MA 10$18.26BUY
MA 20$18.00BUY
MA 50$20.51SELL
MA 100$20.47SELL
MA 200$19.95SELL
Current $EPC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$19.08BUY
EMA 10$18.60BUY
EMA 20$18.75BUY
EMA 50$19.68BUY
EMA 100$20.09SELL
EMA 200$21.21SELL
Current $EPC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-05-08
Maintains
NeutralNeutral
Barclays2026-02-10
Maintains
Equal WeightEqual Weight
Wells Fargo2026-02-10
Maintains
OverweightOverweight
Wells Fargo2026-01-05
Maintains
OverweightOverweight
Morgan Stanley2025-11-18
Maintains
Equal WeightEqual Weight
Barclays2025-11-14
Maintains
Equal WeightEqual Weight
Wells Fargo2025-11-14
Maintains
OverweightOverweight
RBC Capital2025-11-14
Maintains
OutperformOutperform
Wells Fargo2025-09-25
Maintains
OverweightOverweight
Barclays2025-08-06
Maintains
Equal WeightEqual Weight

Wall Street analysts have recently issued updated ratings on Edgewell Personal Care Company (EPC) stock. Of the recent 133 rating actions, 11 were upgrades and 9 were downgrades. 17 analysts currently cover EPC.

Analyst Recommendation Trends

Buy ratings101
Hold ratings312
Sell ratings00

EPC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.3B

↑ 13.6% YoY

Revenue Next Year

$2.2B

↓ 2.3% YoY

EPS This Year

$3.00

EPS Next Year

$2.66

↓ 11.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EPC EPS of $3.00 for the current fiscal year, based on estimates from 6 analysts. The EPC revenue forecast is $2.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The EPC stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EPC price target is $23.50 (+18.3% upside), with an analyst consensus of Hold.

The EPC short-term stock prediction for tomorrow is $20.50 (+3.16%). The EPC stock price prediction for 2027 estimates an average of $17. The EPC stock prediction for 2030 projects a range of $14–$16.

Edgewell Personal Care Company trades on NYSE under the ticker EPC. The EPC stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 35% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

EPC forecast · 8 questions

According to 17 Wall Street analysts, the average 12-month EPC price target is $23.50, with a high forecast of $26.00 and a low of $21.00. The median price target is shown in the chart above when available. This implies +18.3% potential upside from the current price of $19.87.

EPC price targetWhat is EPC price targetEPC analyst price targetEPC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.